Revenue
228 million USD
2026-07-04 · USD
Exact inputs and evidence
- Revenue: 228189000 USD Source
Fundies. English
SILICON LABORATORIES INC.
EDGARAnnual consolidated revenue for 2025: about USD 784.8M, using the latest reported figures. The previous period, 2024, was about USD 584.4M.
Latest quarter
Operating margin
-4.67%
2026-07-04 · %
Operating cash flow
-14.5 million USD
2026-07-04 · USD
Free cash flow
-26.8 million USD
2026-07-04 · USD
- Cash and cash equivalents
- 362 million USD Source
Exact value
362191000 USD
- Long-term debt including current maturities
- Not available
- Shares outstanding
- 33.4 million shares Source
Exact value
33366000 shares
Reported share-count change
1.68% · 551 thousand shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
Trailing twelve months
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
Net income
-39.1 million USD
2025-07-06 – 2026-07-04
Exact inputs and evidence
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-08-11.
Financial data available through: 2026-01-03.
Coverage by financial measure
- Revenue: 4 of 11 periods available· newest 2026-01-03
- Operating income: 4 of 11 periods available· newest 2026-01-03
- Net income: 3 of 11 periods available· newest 2026-01-03
- Operating cash flow: 4 of 11 periods available· newest 2026-01-03
- Capital expenditure: 4 of 11 periods available· newest 2026-01-03
- Total assets: 3 of 11 periods available· newest 2026-01-03
- Total liabilities: 3 of 11 periods available· newest 2026-01-03
- Current assets: 3 of 11 periods available· newest 2026-01-03
- Current liabilities: 3 of 11 periods available· newest 2026-01-03
- Cash and cash equivalents: 3 of 11 periods available· newest 2026-01-03
- long term debt: No compatible figures in this window
- Shares outstanding: 3 of 11 periods available· newest 2026-01-03
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Revenue
+34.3%Prior period
USD 584.39 million
–
Current period
USD 784.76 million
–
Exact inputs and evidence
784764000 − 584386000 = 200378000 USD
584386000 USD · 2023-12-31 – 2024-12-28
Inspect prior input Prior source784764000 USD · 2024-12-29 – 2026-01-03
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 126.1 millionPrior period
−USD 191.01 million
–
Current period
−USD 64.91 million
–
Exact inputs and evidence
-64907000 − -191010000 = 126103000 USD
-191010000 USD · 2023-12-31 – 2024-12-28
Inspect prior input Prior source-64907000 USD · 2024-12-29 – 2026-01-03
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 109.62 millionPrior period
−USD 13.91 million
–
Current period
USD 95.71 million
–
Exact inputs and evidence
95708000 − -13910000 = 109618000 USD
-13910000 USD · 2023-12-31 – 2024-12-28
Inspect prior input Prior source95708000 USD · 2024-12-29 – 2026-01-03
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+154.7%Prior period
USD 11.75 million
–
Current period
USD 29.92 million
–
Exact inputs and evidence
29922000 − 11748000 = 18174000 USD
11748000 USD · 2023-12-31 – 2024-12-28
Inspect prior input Prior source29922000 USD · 2024-12-29 – 2026-01-03
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
2025 2024-12-29 – 2026-01-03
- Revenue USD 784.76 million 100% of revenue
- Cost of revenue USD 327.78 million 42% of revenue
- Operating expenses USD 527.52 million 67% of revenue
- Operating income −USD 70.54 million −9% of revenue
- Tax, interest and other Derived −USD 5.63 million −0.7% of revenue
- Net income −USD 64.91 million −8.3% of revenue
Cash
- Operating cash flow USD 95.71 million 12% of revenue
- Capital expenditure USD 29.92 million 3.8% of revenue
- Free cash flow Derived USD 65.79 million 8.4% of revenue
Share of revenue by period
- Net income
- Tax, interest and other
- Operating costs
- 2022 Not shown: operating income or net income is not reported.
- 2023 Operating loss: operating costs were 103% of revenue.
- 2024 Operating loss: operating costs were 128% of revenue.
- 2025 Operating loss: operating costs were 109% of revenue.
Values and sources
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2022 2022-01-02 – 2022-12-31 | 1024106000 | 904846000 Derived | 119260000 | Unavailable | Unavailable | 114749000 Derived | Source
|
| 2023 2023-01-01 – 2023-12-30 | 782258000 | 806412000 Derived | -24154000 | 10362000 Derived | -34516000 | -52630000 Derived | Source
|
| 2024 2023-12-31 – 2024-12-28 | 584386000 | 749876000 Derived | -165490000 | 25520000 Derived | -191010000 | -25658000 Derived | Source
|
| 2025 2024-12-29 – 2026-01-03 | 784764000 | 855305000 Derived | -70541000 | -5634000 Derived | -64907000 | 65786000 Derived | Source
|
Amounts are exact, in USD.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
USD 784.8M 2025
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2022 | Revenue | 1024106000 |
|
| 2023 | Revenue | 782258000 |
|
| 2024 | Revenue | 584386000 |
|
| 2025 | Revenue | 784764000 |
|
Revenue growth
Change in revenue from the same financial period one year earlier.
34.3% 2025
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2022 | Year over year | No prior comparable period |
|
| 2023 | Year over year | -23.6% |
|
| 2024 | Year over year | -25.3% |
|
| 2025 | Year over year | 34.3% |
|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
Operating margin -9% 2025
Net margin -8.3% 2025
Free cash flow margin 8.4% 2025
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2022 | Operating margin | 11.6% |
|
| 2023 | Operating margin | -3.1% |
|
| 2024 | Operating margin | -28.3% |
|
| 2025 | Operating margin | -9% |
|
| 2022-12-31 | Net margin | Not reported |
|
| 2023 | Net margin | -4.4% |
|
| 2024 | Net margin | -32.7% |
|
| 2025 | Net margin | -8.3% |
|
| 2022 | Free cash flow margin | 11.2% |
|
| 2023 | Free cash flow margin | -6.7% |
|
| 2024 | Free cash flow margin | -4.4% |
|
| 2025 | Free cash flow margin | 8.4% |
|
Operating cash flow
Cash generated by the company’s normal business operations.
USD 95.7M 2025
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2022 | Operating cash flow | 141274000 |
|
| 2023 | Operating cash flow | -30348000 |
|
| 2024 | Operating cash flow | -13910000 |
|
| 2025 | Operating cash flow | 95708000 |
|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
USD 65.8M 2025
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2022 | Free cash flow | 114749000 |
|
| 2023 | Free cash flow | -52630000 |
|
| 2024 | Free cash flow | -25658000 |
|
| 2025 | Free cash flow | 65786000 |
|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
13.8% 2025
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2022-12-31 | Liabilities / assets | Not reported | No source recorded |
| 2023 | Liabilities / assets | 16.2% |
|
| 2024 | Liabilities / assets | 11.7% |
|
| 2025 | Liabilities / assets | 13.8% |
|
Current assets to current liabilities
Current assets divided by current liabilities.
4.69× 2025
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2022-12-31 | Current assets / current liabilities | Not reported | No source recorded |
| 2023 | Current assets / current liabilities | 4.51× |
|
| 2024 | Current assets / current liabilities | 6.15× |
|
| 2025 | Current assets / current liabilities | 4.69× |
|
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2022 2022-01-02 – 2022-12-31 | Unavailable Not reported for this period. | USD 141.27 million Exact valueExact value: 141274000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 26.53 million Exact valueExact value: 26525000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 114.75 million Calculation and evidence141274000 − 26525000 USD Exact free cash flow: 114749000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2023 2023-01-01 – 2023-12-30 | −USD 34.52 million Exact valueExact value: -34516000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 30.35 million Exact valueExact value: -30348000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 22.28 million Exact valueExact value: 22282000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 52.63 million Calculation and evidence-30348000 − 22282000 USD Exact free cash flow: -52630000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2024 2023-12-31 – 2024-12-28 | −USD 191.01 million Exact valueExact value: -191010000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 13.91 million Exact valueExact value: -13910000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 11.75 million Exact valueExact value: 11748000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 25.66 million Calculation and evidence-13910000 − 11748000 USD Exact free cash flow: -25658000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2025 2024-12-29 – 2026-01-03 | −USD 64.91 million Exact valueExact value: -64907000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 95.71 million Exact valueExact value: 95708000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 29.92 million Exact valueExact value: 29922000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 65.79 million Calculation and evidence95708000 − 29922000 USD Exact free cash flow: 65786000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
185 filings · 6,964 latest values · 6,964 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001038074, 1038074, SLAB, edgar:1038074
Also known as SILICON LABORATORIES INC, SILICON LABORATORIES INC., SILICON LABORATORIES INC.